Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Caspase-3 activity has been described to be essential for drug-induced apoptosis. Recent results suggest that in addition to its downstream executor function, caspase-3 is also involved in the processing of upstream caspase-8 and -9. To test the absolute requirement for caspase-3, we examined mitomycin C (MMC)-induced apoptosis in the caspase-3 deficient human breast cancer cell line MCF-7. MMC was used as anticancer drug since this agent was preferentially active compared to chemotherapeutic compounds with differing mechanisms of action such as cisplatin, docetaxel, or lovastatin. MMC treatment led to pronounced caspase-8, -9, and -7 processing and early morphological features of apoptosis within 48 h. This could be inhibited by the broad-spectrum caspase inhibitor z-VAD.fmk and to a lesser extent by z-IETD.fmk and z-LEHD.fmk, which have a certain preference for inhibiting caspase-8 and -9, respectively. MMC induced apoptosis in MCF-7 cells was not mediated by the death receptor pathway as demonstrated by experiments using the inhibiting anti-Fas antibody ZB4 and transfections with CrmA, a viral serpin inhibitor of caspase-8, and the dominant negative Fas-associated death domain (FADD-DN). Stable expression with Bcl-2 significantly prevented the processing of caspase-9 but also of caspase-8 and blocked the induction of apoptosis. Thus, we provide evidence that caspase-3 activity is dispensable for MMC-induced apoptosis and for caspase-8 and -9 processing in MCF-7 cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“leads to pronounced induction of the mitochondrial-dependent intrinsic apoptotic pathway [6].”
From Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer (2024) · cites this paper as [6]
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., & Nagata, S. (1998) · Nature · doi:10.1038/34112 · Cited by 3,189
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Earnshaw, W. C., Martins, L. M., & Kaufmann, S. H. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.383 · Cited by 2,760
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I., Oliver, H., Lutter, M., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,565
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Chinnaiyan, A. M., O'Rourke, K., Tewari, M., & Dixit, V. M. (1995) · Cell · doi:10.1016/0092-8674(95)90071-3 · Cited by 2,431
Nicholson, D. W., & Thornberry, N. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01085-2 · Cited by 2,409
Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., & Dixit, V. M. (1995) · Cell · doi:10.1016/0092-8674(95)90541-3 · Cited by 2,367
An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9
Zou, H., Li, Y., Liu, X., & Wang, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11549 · Cited by 2,090
Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis
Jänicke, R. U., Sprengart, M. L., Wati, M. R., & Porter, A. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9357 · Cited by 1,953
Slee, E. A., Harte, M. T., Kluck, R. M., Wolf, B. B., Casiano, C. A., Newmeyer, D. D., Wang, H.-G., Reed, J. C., Nicholson, D. W., Alnemri, E. S., et al. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.2.281 · Cited by 1,929
Autoactivation of Procaspase-9 by Apaf-1-Mediated Oligomerization
Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., & Alnemri, E. S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80095-7 · Cited by 1,119
Friesen, C., Herr, I., Krammer, P. H., & Debatin, K.-M. (1996) · Nature Medicine · doi:10.1038/nm0596-574 · Cited by 974
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878 · cited 4×
“This is in line with other reports on a disabled Fas pathway in this cell line,38 which is not induced by DNA damaging agents such as MMC.39 Our results suggest a purely intracellular mechanism of caspase-8 activation analogous to the activation of caspase-9 within the apoptosome.”
ResultInfluentialEssential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
Woo, M., Hakem, R., Soengas, M. S., Duncan, G. S., Shahinian, A., Kagi, D., Hakem, A., McCurrach, M., Khoo, W., Kaufman, S. A., et al. (1998) · Genes & Development · doi:10.1101/gad.12.6.806 · Cited by 840
Distinct Caspase Cascades Are Initiated in Receptor-mediated and Chemical-induced Apoptosis
Sun, X.-M., MacFarlane, M., Zhuang, J., Wolf, B. B., Green, D. R., & Cohen, G. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5053 · Cited by 820
Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.
Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H., & Cory, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00304.x · Cited by 784
Deveraux, Q. L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5242 · Cited by 751
Müller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119174 · Cited by 748
Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.
Fritsche, M., Haessler, C., & Brandner, G. (1993) · PubMed · Cited by 747
Strasser, A. (1994) · Cell · doi:10.1016/0092-8674(94)90201-1 · Cited by 666
Apaf-1 is a transcriptional target for E2F and p53
Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K. (2001) · Nature Cell Biology · doi:10.1038/35078527 · Cited by 593 · cited 2×
“, unpublished results),(48,49) our findings could be interpreted in the context of recent data, which show p53 to be crucially involved in the transcriptional activation of APAF-1.(50) Thus, the potent p53 stimulatory effect of MMC resulting in transcriptional activation of death pathway components may override the la…”
ResultLiu, X., Li, P., Widlak, P., Zou, H., Luo, X., Garrard, W. T., & Wang, X. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8461 · Cited by 529
Inhibition of Fas death signals by FLIPs
Tschopp, J., Irmler, M., & Thome, M. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80223-9 · Cited by 520
Target Protease Specificity of the Viral Serpin CrmA
Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V. M., & Salvesen, G. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7797 · Cited by 519
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.
Keyomarsi, K., Sandoval, L. S., Band, V., & Pardee, A. B. (1991) · PubMed · Cited by 505
Newton, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.706 · Cited by 499
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda, S., Sieverts, H., Friesen, C., Herr, I., & Debatin, K. (1997) · PubMed · Cited by 482
Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid
Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., & Debatin, K.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33942 · Cited by 369
Molecular effects of paclitaxel: Myths and reality (a critical review)
Blagosklonny, M. V., & Fojo, T. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991008)83:2<151::aid-ijc1>3.0.co;2-5 · Cited by 363
Fulda, S., Friesen, C., Łoś, M., Scaffidi, C., Mier, W., Benedict, M., Núñez, G., Krammer, P. H., Peter, M. E., & Debatin, K. (1997) · PubMed · Cited by 342
Yang, X. H., Sladek, T. L., Liu, X., Butler, B. R., Froelich, C. J., & Thor, A. D. (2001) · PubMed · Cited by 299
Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL
Huang, D. C. S., Hahne, M., Schroeter, M., Frei, K., Fontana, A., Villunger, A., Newton, K., Tschopp, J., & Strasser, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14871 · Cited by 297
Wesselborg, S., Engels, I. H., Rossmann, E., Los, M., & Schulze-Osthoff, K. (1999) · Blood · doi:10.1182/blood.v93.9.3053 · Cited by 292
Jiang, C., Wang, Z. P., Ganther, H. E., & Lü, J. (2001) · PubMed · Cited by 270
Eischen, C. M., Kottke, T. J., Martins, L. M., Basi, G. S., Tung, J. S., Earnshaw, W. C., Leibson, P. J., & Kaufmann, S. H. (1997) · Blood · doi:10.1182/blood.v90.3.935 · Cited by 269
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis
Engels, I. H., Stepczynska, A., Stroh, C., Lauber, K., Berg, C., Schwenzer, R., Wajant, H., Jänicke, R. U., Porter, A. G., Belka, C., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203824 · Cited by 252
Wieder, T., Essmann, F., Prokop, A., Schmelz, K., Schulze-Osthoff, K., Beyaert, R., Dörken, B., & Daniel, P. T. (2001) · Blood · doi:10.1182/blood.v97.5.1378 · Cited by 247
Blanc, C., Deveraux, Q. L., Krajewski, S., Jänicke, R. U., Porter, A. G., Reed, J. C., Jaggi, R. B., & Marti, A. (2000) · PubMed · Cited by 237
Ferreira, C. G., Span, S. W., Peters, G. J., Kruyt, F. A. E., & Giaccone, G. (2000) · PubMed · Cited by 223
Tishler, R. B., Calderwood, S. K., Coleman, C. N., & Price, B. D. (1993) · PubMed · Cited by 200
Villunger, A., Egle, A., Kos, M., Hartmann, B. L., Geley, S., Kofler, R., & Greil, R. (1997) · PubMed · Cited by 181
Ferreira, C. G., Tolis, C., & Giaccone, G. (1999) · Annals of Oncology · doi:10.1023/a:1008361818480 · Cited by 174
Newton, K., & Strasser, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.195 · Cited by 143
Tsujimoto, Y. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.6.1958 · Cited by 137
Friedrich, K., Wieder, T., von Haefen, C., Radetzki, S., Jänicke, R. U., Schulze‐Osthoff, K., Dörken, B., & Daniel, P. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204342 · Cited by 135
Johnson, V. L., Ko, S. C. W., Holmstrom, T. H., Eriksson, J. E., & Chow, S. C. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.17.2941 · Cited by 133
Borner, M., Myers, C. E., Sartor, O. A., Sei, Y., Toko, T., Trepel, J. B., & Schneider, E. (1995) · PubMed · Cited by 112
Self-citationCutts, S. M., Parsons, P. G., Sturm, R. A., & Phillips, D. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5422 · Cited by 64
The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
Tolomeo, M., Dusonchet, L., Meli, M., Grimaudo, S., D’Alessandro, N., Papoff, G., Ruberti, G., & Rausa, L. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400406 · Cited by 53
Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin
Jain, N., Lam, Y.-M., Pym, J., & Campling, B. G. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960501)77:9<1797::aid-cncr7>3.0.co;2-9 · Cited by 46
Kovar, H., Jug, G., Printz, D., Bartl, S., Schmid, G., & Węsierska‐Gądek, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203780 · Cited by 33
Uncertain Identity of Doxorubicin-Resistant MCF-7 Cell Lines Expressing Mutated p53
Pirnia, F., Breuleux, M., Schneider, E., Hochmeister, M., Bates, S. E., Marti, A., Hotz, M. A., Betticher, D. C., & Borner, M. M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1535 · Cited by 25
Self-citation
Cited by
Afaq, F., Syed, D. N., Malik, A., Hadi, N., Sarfaraz, S., Kweon, M.-H., Khan, N., Zaid, M. A., & Mukhtar, H. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700510 · Cited by 239
Qu, J., Huang, P., Zhang, L., Qiu, Y., Qi, H., Leng, A., & Shang, D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.196 · Cited by 165
Haddad, S., Abánades Lázaro, I., Fantham, M., Mishra, A., Silvestre-Albero, J., Osterrieth, J. W. M., Kaminski Schierle, G. S., Kaminski, C. F., Forgan, R. S., & Fairen-Jimenez, D. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c00188 · Cited by 161
Kawamura, T., Huang, C., Tochigi, N., Lee, S., Shigemura, N., Billiar, T. R., Okumura, M., Nakao, A., & Toyoda, Y. (2010) · Transplantation · doi:10.1097/tp.0b013e3181fe1357 · Cited by 157
Lin, P., & Ye, R. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209101200 · Cited by 143
Metadata
- Authors
- Pirnia, F., Schneider, E., Betticher, D. C., & Borner, M. M.
- Affiliations
- University of Bern (CH)
- New York State Department of Health (US)
- Corresponding author
- Borner, M M
- ORCID
- Betticher, D C
- Venue
- Cell Death & Differentiation
- Published
- 2002-08-16
- Volume
- 9
- Issue
- 9
- Pages
- 905-914
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2025713628
- Cited by
- 151
- References
- 55
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 3 · 2020: 7 · 2019: 7 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 8 · 2014: 7 · 2013: 11 · 2012: 8
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Calpain Protease Function and Regulation
- Keywords
- mitomycin C, apoptosis, caspase-3, caspase-8, caspase-9, caspase-7, death receptor signaling, Bcl-2, MCF-7 cells, caspase inhibitors, CrmA, FADD, z-VAD-fmk
- MeSH terms
- Antibiotics, Antineoplastic, Breast Neoplasms, Carcinoma, Enzyme Inhibitors, Female, Humans, Tumor Cells, Cultured, Signal Transduction, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Mitomycin, Apoptosis, fas Receptor, Proto-Oncogene Proteins c-bcl-2, Caspases, Caspase 3, Caspase 7, Caspase 8, Caspase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.